Fingerprint
Dive into the research topics of 'Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
OA Khan, Andrew Blann, MJ Payne, MR Middleton, AS Protheroe, DC Talbot, M Taylor, C Han, M Patil, AL Harris
Research output: Contribution to journal › Article
25
Citations
(Scopus)